{"database": "lobbying", "table": "lobbying_activities", "rows": [[954451, "5a3ba48b-df90-4a78-9914-44a79c2e0358", "Q2", "POLICY DIRECTIONS INC.", 31747, "ADVANCED LIFE SCIENCES", 2010, "second_quarter", "MED", "FDA regulatory pathway for new antibiotic medicines.\nHR 2400, Strategies to Address Antimicrobial Resistance Act, portions related to introduction of and regulatory policy of new antimicrobial candidates.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2010-07-15T12:53:14.060000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["954451"], "units": {}, "query_ms": 0.3292560577392578, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}